Diabetes is a chronic disease caused by either a deficiency in insulin production or insulin resistance. In type 1 diabetes, the body does not produce insulin, a hormone needed to…
Recently, we were fortunate to send a small contingent to the Asembia 2021 Specialty Pharmacy Summit held in Las Vegas, Nevada, on October 26 – 29, 2021. After a year…
The specialty drug pipeline is a critical component in building a successful specialty pharmacy program. Staying abreast of what is on the horizon and successfully planning and executing is key…
On September 15th, we hosted a panel discussion on The Evolution of Health System Specialty Pharmacy. An esteemed panel of specialty pharmacists helped us understand why a more mature specialty…
Walgreens Boots Alliance is investing $970 million for a majority stake in a specialty pharmacy company that works with hospitals and health systems to set up and run their own…
DEERFIELD, Ill. & BOSTON–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) and Shields Health Solutions today announced that WBA, through its wholly-owned subsidiary, Walgreen Co., is making a majority investment in…
The company will pay $970 million to increase its ownership of the Stoughton-based specialty pharmacy company to 71 percent
This blog was authored by the following members of our trade relations team: Kerry Mello-Parker, Director of Clinical Compliance, MJ Kelly, Medical Billing Specialist, Ben May, Director of Drug Trend…
The explosion of Specialty Pharmacies within the health system space over the past several years has been well documented. As health systems assume more of the risk for outcomes and total…
MINNEAPOLIS–(BUSINESS WIRE)–Excelera®, a wholly-owned subsidiary of Shields Health Solutions and the company behind the Excelera Network, announced today a new specialty pharmacy-focused educational offering in partnership with Aptitude Health, which provides critical insights…